Nacuity Pharmaceuticals

Nacuity Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on developing treatments for retinitis pigmentosa (RP) and potentially other ophthalmic indications. Nacuity has assembled an accomplished team and secured substantial funding and technical support from the Foundation Fighting Blindness (FFB). The mission of FFB is to provide prevention and treatment for retinal diseases that cause blindness. Over the past nearly 50 years, FFB has invested more than $700 million in this area.